In COVID-19, therapeutic vs. prophylactic anticoagulation did not improve clinical outcomes and increased bleeding
- 5 October 2021
- journal article
- editorial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (10), JC112
- https://doi.org/10.7326/acpj202110190-112
Abstract
Source Citation Lopes RD, de Barros E Silva PG, Furtado RH, et al. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration... Clinical Impact Ratings Hospitalists: 6 out of 7 Infectious Disease: 7 out of 7 Critical Care: 7 out of 7This publication has 4 references indexed in Scilit:
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19The New England Journal of Medicine, 2021
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19The New England Journal of Medicine, 2021
- COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 yearThe Lancet Haematology, 2021
- American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19Blood Advances, 2021